Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies
Clinical trial NCT04230265 · TERMINATED
Trial details
- NCT number
- NCT04230265
- Sponsor
- AvenCell Europe GmbH
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-28
- Primary completion
- 2025-04-11
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.